OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Company limited by guarantee

Company Registration Number:
12009294 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2023

Period of accounts

Start date: 1 June 2022

End date: 31 May 2023

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Contents of the Financial Statements

for the Period Ended 31 May 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Directors' report period ended 31 May 2023

The directors present their report with the financial statements of the company for the period ended 31 May 2023

Directors

The directors shown below have held office during the whole of the period from
1 June 2022 to 31 May 2023

Anthony Salla
Jacqueline Maria DYER
Edward Kotia NEEQUAYE


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
8 February 2024

And signed on behalf of the board by:
Name: Anthony Salla
Status: Director

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Profit And Loss Account

for the Period Ended 31 May 2023

2023 2022


£

£
Turnover: 30,483 31,320
Gross profit(or loss): 30,483 31,320
Administrative expenses: ( 30,482 ) ( 31,320 )
Operating profit(or loss): 1 0
Profit(or loss) before tax: 1 0
Profit(or loss) for the financial year: 1 0

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Balance sheet

As at 31 May 2023

Notes 2023 2022


£

£
Current assets
Cash at bank and in hand: 1 426
Total current assets: 1 426
Creditors: amounts falling due within one year: 3 ( 426 )
Net current assets (liabilities): 1 0
Total assets less current liabilities: 1 0
Total net assets (liabilities): 1 0
Members' funds
Profit and loss account: 1 0
Total members' funds: 1 0

The notes form part of these financial statements

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Balance sheet statements

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 8 February 2024
and signed on behalf of the board by:

Name: Anthony Salla
Status: Director

The notes form part of these financial statements

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 0 0

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 May 2023

3. Creditors: amounts falling due within one year note

  2022
  £
Accruals and deferred income 426
Total   426

COMMUNITY INTEREST ANNUAL REPORT

OXYTOCIN-LEARNING COMMUNITY INTEREST COMPANY

Company Number: 12009294 (England and Wales)

Year Ending: 31 May 2023

Company activities and impact

During the last financial year Oxytocin-Learning continued with a key area of work embarkedproviding culturally appropriate provision. This entailed partnership work with Black ThriveGlobal to offer culturally appropriate advocacy training. Oxytocin Learning also engaged inwork with Thrive London promoting citywide public mental health.

Consultation with stakeholders

The stakeholders of Oxytocin-Learning are people who access the support that is provided. The stakeholders are engaged to find out what their needs are. As a result of this engagement the directors try to source funds to meet necessary needs.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
7 February 2024

And signed on behalf of the board by:
Name: Anthony Salla
Status: Director